[ABMD] ABIOMED, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 5.06 B

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 112.38 Change: 0.83 (0.74%)
Ext. hours: Change: 0 (0%)

chart ABMD

Refresh chart

Strongest Trends Summary For ABMD

ABMD is in the long-term up 2962% in 9 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart fai

Fundamental Ratios
Shares Outstanding42.99 M EPS1.16 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 38.41% Sales Growth - Q/Q8.95% P/E123.61
P/E To EPS Growth P/S21.98 P/BV17.37 Price/Cash Per Share38.37
Price/Free Cash Flow132.89 ROA33.6% ROE38.99% ROI
Current Ratio5.6 Quick Ratio5.17 Long Term Debt/Equity Debt Ratio0.13
Gross Margin82.66% Operating Margin12.45% Net Profit Margin49.36% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities9.52 M Cash From Investing Activities-49.86 M Cash From Operating Activities43.29 M Gross Profit56.75 M
Net Profit98.87 M Operating Profit12.36 M Total Assets338.37 M Total Current Assets220.14 M
Total Current Liabilities39.32 M Total Debt Total Liabilities46.81 M Total Revenue67.56 M
Technical Data
High 52 week418.21 Low 52 week137.43 Last close418.21 Last change2.06%
RSI74.47 Average true range12.71 Beta1.13 Volume141.67 K
Simple moving average 20 days6.46% Simple moving average 50 days21.82% Simple moving average 200 days72.66%
Performance Data
Performance Week3.05% Performance Month13.37% Performance Quart41.89% Performance Half122.56%
Performance Year196.12% Performance Year-to-date123.15% Volatility daily1.43% Volatility weekly3.2%
Volatility monthly6.56% Volatility yearly22.72% Relative Volume291.59% Average Volume752.5 K
New High New Low

News

2019-06-13 14:00:00 | Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Women’s Health

2019-06-10 08:03:00 | See what the IHS Markit Score report has to say about Abiomed Inc.

2019-06-07 09:58:07 | Abiomed, Inc. NASDAQ:ABMD: Will The Growth Last?

2019-06-05 08:14:12 | New Strong Sell Stocks for June 5th

2019-06-04 15:33:27 | Not Just Uber: 5 Stocks Analysts Love Unanimously

2019-06-01 09:31:01 | Why Is Abiomed ABMD Up 0.6% Since Last Earnings Report?

2019-05-31 17:45:09 | Abiomed ABMD Dips More Than Broader Markets: What You Should Know

2019-05-29 09:34:00 | Abiomed to Present at Upcoming Investor Conferences

2019-05-23 17:48:08 | Abiomed Inc ABMD Files 10-K for the Fiscal Year Ended on March 31, 2019

2019-05-22 09:58:01 | ABIOMED Gets FDA Confirmation of the Safety of Impella RP

2019-05-22 06:05:17 | FDA clears Abiomed heart pump after concerns over death rate

2019-05-21 12:42:00 | FDA Confirms Impella RP is Safe and Effective; Only Right-Sided Device with FDA Approval

2019-05-21 12:15:00 | National Cardiogenic Shock Initiative NCSI with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery

2019-05-20 07:36:11 | ABIOMED ABMD to Launch Impella CP With SmartAssist at SCAI

2019-05-16 08:00:00 | Impella SmartAssist Platform Launches at SCAI, Designed to Further Improve Patient Outcomes

2019-05-14 07:34:11 | ABIOMED's Impella 5.0 and LD Receive Expanded FDA Approvals

2019-05-13 12:00:00 | FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

2019-05-13 10:16:55 | Is ABIOMED, Inc.'s NASDAQ:ABMD High P/E Ratio A Problem For Investors?

2019-05-13 02:30:00 | Abiomed and Intersect ENT Stumble to Start 2019

2019-05-10 16:14:00 | ShockWave Medical's Revenue Soars in Its Public Debut

2019-05-10 12:02:00 | 2 Winners and 2 Losers in the Med Tech Market This Quarter

2019-05-07 08:05:49 | See what the IHS Markit Score report has to say about Abiomed Inc.

2019-05-06 14:24:26 | Speedy Medtech: Why This Fast-Growing Stock Should Be On Your Radar

2019-05-02 17:41:53 | Edited Transcript of ABMD earnings conference call or presentation 2-May-19 12:00pm GMT

2019-05-02 17:31:31 | ABIOMED Inc. ABMD Q4 2019 Earnings Call Transcript

2019-05-02 16:32:46 | Qualcomm and Tesla rise while Abiomed and Fluor fall

2019-05-02 16:09:04 | Medtech CEO Promises To 'Correct The Course' As Shares Dive On Sales Lag

2019-05-02 15:35:06 | Abiomed Comes Up Short as Growth Slows

2019-05-02 10:41:00 | Abiomed Shares Fall Following Revenue Miss and Poor Guidance

2019-05-02 10:36:44 | US STOCKS-Wall St inches higher with earnings in spotlight

2019-05-02 09:14:02 | US STOCKS-Wall St set for mixed open with earnings in spotlight

2019-05-02 08:49:12 | ABIOMED ABMD Q4 Earnings Meet Estimates, Sales Rise in Japan

2019-05-02 08:25:12 | Abiomed ABMD Matches Q4 Earnings Estimates

2019-05-02 07:32:34 | Abiomed: Fiscal 4Q Earnings Snapshot

2019-05-02 07:05:00 | FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

2019-05-02 07:00:00 | Abiomed Announced Q4 FY 2019 Revenue of $207 Million and 31.6% Operating Margin

2019-05-02 06:00:00 | ABIOMED, Inc. to Host Earnings Call

2019-05-01 10:00:02 | Varian's VAR Halcyon to Treat Patients at Japan's Hospital

2019-04-29 10:31:02 | Will Flagship Impella Drive ABIOMED's ABMD Q4 Earnings?

2019-04-27 18:00:00 | 3 Top Healthcare Stocks to Buy Right Now

2019-04-25 17:45:09 | Abiomed ABMD Dips More Than Broader Markets: What You Should Know

2019-04-25 10:33:02 | Abiomed ABMD Earnings Expected to Grow: What to Know Ahead of Next Week's Release

2019-04-23 09:28:00 | Clinical Data Highlights Advantages of Protected PCI to Enable Complete Revascularization and Improved Patient Quality of Life

2019-04-22 13:55:19 | The ABIOMED NASDAQ:ABMD Share Price Is Up 939% And Shareholders Are Delighted

2019-04-19 09:30:01 | TMO or ABMD: Which Is the Better Value Stock Right Now?

2019-04-19 09:15:58 | Jim Cramer Weighs In On Campbell Soup, Funko, Marvell Technology And More

2019-04-18 17:45:09 | Abiomed ABMD Outpaces Stock Market Gains: What You Should Know

2019-04-12 17:45:09 | Abiomed ABMD Stock Sinks As Market Gains: What You Should Know

2019-04-12 10:10:02 | Why Abiomed ABMD Could Beat Earnings Estimates Again

2019-04-12 09:08:01 | Will Instruments Drive Intuitive Surgical ISRG Q1 Earnings?